← Back to headlines
Arcellx Sells $80 Million in Stock Following Steep Drop and Rival Drug Emergence
Arcellx has completed an $80 million stock sale, which comes after a significant drop in its stock price and the emergence of a rival drug in the market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
